Home / Companies / Rapt Therapeutics, Inc. / 29 May 2025
Rapt Therapeutics, Inc.: meeting of 29 May 2025
Votes reported on Form N-PX, item by item
144 Form N-PX filers reported votes at the Rapt Therapeutics, Inc. meeting of 29 May 2025. Their records fall into 6 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
1 nominee; 10.3% of reported votes for; 49 filers withheld from or voted against at least one nominee.
97 vote records from 57 filers. 48 of the 57 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
200 vote records from 143 filers. 114 of the 138 filers that marked the item either way voted against management. 5 filers reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Frequency of the say-on-pay vote
one year: 126 filers; three years: 5 filers; for: 4 filers; abstain: 1 filer; against: 1 filer; none: 1 filer.
200 vote records from 142 filers. 6 of the 137 filers that marked the item either way voted against management. 5 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
97 vote records from 57 filers. 0 of the 57 filers that marked the item either way voted against management.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
103 vote records from 57 filers. 2 of the 57 filers that marked the item either way voted against management.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
188 vote records from 57 filers. 5 of the 57 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Pay-vote frequency | 4. Auditor |
|---|---|---|---|---|
| Vanguard | Abstain or withhold * | Against * | Split or no vote | For |
| BlackRock and iShares | Abstain or withhold * | Against * | Split or no vote | For |
| Fidelity | Abstain or withhold * | Against * | Split or no vote | For |
| Dimensional | Abstain or withhold * | Against * | Split or no vote * | For |
| State Street and SPDR | For | For | Split or no vote | For |
| Invesco | Abstain or withhold * | Against * | Split or no vote | For |
| Equitable | Abstain or withhold * | Against * | Split or no vote | For |
| Charles Schwab | Abstain or withhold * | Against * | Split or no vote | For |
| Nuveen and TIAA | For | Against * | Split or no vote | For |
| ProShares and ProFunds | Abstain or withhold * | Against * | Split or no vote | For |
| Morgan Stanley, Eaton Vance and Calvert | Abstain or withhold * | Against * | Split or no vote | For |
| J.P. Morgan | No report | Against * | Split or no vote | No report |
| Goldman Sachs | Abstain or withhold * | Against * | Split or no vote | For |
| PGIM and Prudential | No report | Against * | Split or no vote | No report |
| Jackson National funds | Abstain or withhold * | Against * | Split or no vote * | For |
| Northern Trust and FlexShares | Abstain or withhold * | Against * | Split or no vote | For |
| SEI | Abstain or withhold * | Against * | Split or no vote | For |
| T. Rowe Price | Abstain or withhold * | Against * | Split or no vote | For |
| Lincoln Financial | For | For | Split or no vote | For |
| First Trust | No report | Split or no vote | Split or no vote | No report |
| Russell Investments | No report | Against * | Split or no vote | No report |
| Nationwide | Abstain or withhold * | Against * | Split or no vote | For |
| Guggenheim and Rydex | Abstain or withhold * | Against * | Split or no vote | For |
| BNY Mellon | No report | Against * | Split or no vote | No report |
| Principal | No report | Against * | Split or no vote | No report |
| Pacific Life funds | Abstain or withhold * | Against * | Split or no vote | For |
| Global X | Abstain or withhold * | Against * | Split or no vote | For |
| Federated Hermes | Abstain or withhold * | Against * | Split or no vote | For |
| AllianceBernstein | No report | Against * | Split or no vote | No report |
| DWS | Abstain or withhold * | Against * | Split or no vote | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Rapt Therapeutics, Inc. meeting?
144 Form N-PX filers reported votes at the meeting of 29 May 2025. On say-on-pay, 114 of 138 voted against management (82.6%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Rapt Therapeutics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Rapt Therapeutics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Rapt Therapeutics, Inc. with a meeting date within three days of 29 May 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.